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chromosome. Three of nine SSX gene family involve in SYT-SSX translocation are SSX1, SSX2, or SSX4. The presence of SYT-SSX transcript in almost all synovial sarcoma cases indicated that the fusion protein play role as tumor etiology.
3 D'Arcy et al reported that SYT-SSX1 fusion protein can enhance stability of HDM2. HDM2 incresases p53 ubiquitinization and p53 degradation. Moreover, SYT-SSX1 shows pro-survival activity and increases cell growth. 4 p53 plays important role to maintain genome integrity. Upon DNA damage, the p53 will be activated. This can leads to cell cycle arrest and induction of DNA repair. If DNA repair fails, p53 triggers apoptosis. In cells with loss or mutation of p53, DNA damage does not induce DNA repair and cell cycle arrest. The genetically Synovial sarcoma is an aggressive tumor than can recur and have metastasis with low surviral rate. 1 The tumor is commonly found in extremity and surgery represents the primary therapy modality. Thus the therapy can render disability to the patient. 2 Synovial sarcoma has two cellular type, spindle cell and epiteloid cell. The proportion of both cell are varied and can be classified as several histological subtypes: biphasic subtype, monophasic subtype (monophasic fibrous or rarely monophasic epithelial), and poor differentiated subtype. 3 The tumors contain characteristic translocation t(X;18) (p11.2;q11.2) that produce fusion of SYT gene in chromosome 18 with member of SSX gene family in X damaged cells proliferate and may leads to malignant neoplasms. 5, 6 It has been reported that the prognosis associated with mitosis <10/10 HPF (high power field), tumor diameter <5 cm, no necrosis, patients age ≤ 20 years and if tumor can be eradicated by surgery. 1 To date, factors that associated with the tumor patogenesis and prognosis still investigated. Therefore the objective of this study was to know the pattern of p53 expresion and to evaluate its association with mitosis, histological subtype, and other prognosis factors. 
METHODS

Diagnosis
p53 expressions
The tumor p53 expression were observed through immunohistochemistry. The cases were grouped as negative p53 expression if the stain intensity 0-weak or if the tumor cell stained less than 10% and as possitive p53 expression if the nuclei stained moderate-strong and the tumor cell stained 10% or more. The examination performed through digital camera Olympus DP25 from 10 HPF (40x objective lens) Olympus BX51 microscop and then counted with ImageJ 1.46n software.
Paraffin block materials were cut 2-5 µm thick, mounted on glass slides coated by poly-l-lysine. The sections were deparafinized in xylene and rehydrated in ethanol, and endogenous peroxidase was blocked by methanol containing 0,5% H 2 O 2 for 30 min. For antigen retrieval, sections were pretreated with citrate buffer, at power level 8 and 1 each for 5 min in a microwave oven. For blocking unspesific staining, the sections were treated with bacground sniper (Biocare) for 30 min. The sections were incubated with primary antibody (1:750, monoclonal mouse anti-human p53 protein, M7001, DAKO Cytomation) at room temperature for 60 min. Then followed by treating with a Starr Trek universal HRP detection system (Biocare). The sections were finally reacted with Betazoid DAB chromogen solution (Biocare) and counterstained with haematoxylin.
Mitosis
The haematoxylin-eosin slides (which were coded) were used to count mitosis (metaphase or anaphase) microscopically on 10 HPF (40x objective lens). The cases were grouped as mitosis <10/10 HPF group and ≥10/10 HPF group. The counting was done three times, one time by the author and twice by co-author. The results then summed and averaged.
Translocation t(X;18) (p11.2;q11.2)
Translocation t(X;18) (p11.2;q11.2) detected by FISH method using ZytoLight ® SPEC SYT Dual Color Break Apart Probe (ZytoVision). This reagent contains two probes, the first probe labeled with orange fluorophore hybridized with sequences distal to the SYT gene and the second probe labeled with green fluorophore hybridized with sequences proximal to the SYT gene. In cell without translocation involving SYT gene, two pairs of green/orange fusion signals appeared. Otherwise if the translocation involving one of SYT gene, one separate green signal and orange signal by a distance more than diameter of one signal appeared ( Figure 1 ). The cases were grouped as FISH positive if the translocations were counted ≥ 20% of 50 nucleus.
Paraffin block materials were cut 2-5 µm thick, mounted on glass slides coated by poly-l-lysine. Sections were incubated on a hot plate at 60 o C for 2 hours and at 70 o C for 10 min. Sections were deparafinized in xylene (2x for 10 min) and rehydrated in ethanol (100%, 100%, 90%, and 70%, each for 5 min) followed by washing in distilled water (2x for 2 min). Sections were then incubated in pre-warmed heat pretreatment solution cytric (PT1, ZytoVision) at 98 o C for 15 min and washed in distilled water (2x for 2 min). For proteolysis, sections were reacted with pepsin solution (ES1, ZytoVision) and incubated at 37 o C in a humidity chamber for 10 min. Then followed by washing with wash buffer ssc (WB1, ZytoVision) for 5 min and with distilled water for 1 min. Sections were dehydrated in ethanol (70%, 90%, and 100% each for 1 min) and air dried. The probe were applied to sections, covered with a coverslip and sealed with rubber cement. Sections were denatured at 75°C for 10 min on a hot plate. Followed by hybridization overnight at 37°C in humidity chamber. Sections were washed with pre-warmed wash buffer A (WB2, ZytoVision) at 37 o C for 3 min and again twice for 5 min. Sections were air dried in the dark then reacted with DAPI/Antifade (MT1, ZytoVision). Sections were covered with coverslip, sealed with nail varnish and incubated in room temperature for 15 min. The samples were analyzed under a fluorescent microscope (100x objective lens with immersion oil, Olympus BX51) 
Statistical analysis
Fisher's exact tests were used to analyze differences between independent variables. Differences were considered significant if p <0.05. The software MYSTAT 12 Version 12.02.00 was used for statistical analysis.
RESULTS
The cases number were equal in female and male, most tumor cases were located at extremity. In one case, the tumor location was unknown because the medical record was incomplete. Majority of the cases were histologically biphasic type. Tumor diameter was classified as <5 cm (9 cases) and ≥5 cm (10 cases) while in one case, the tumor diameter was unknown ( Table 1) .
The results of tumor p53 expresion, mitosis and FISH can be seen in table 2. The p53 positive cases were counted more than negative cases (Figure 2) . Number of cases with mitosis ≥ 10/10 HPF was higher than cases with mitosis <10/10 HPF. The results of FISH revealed, 7/19 cases positive for SYT gene translocation ( Figure  3 ). One case can not be analyzed because of pepsin overdigestion and was not restained because the probe was insufficient. Tumor diameter was associated with p53 expression (p <0.05) although tumor diameter was not associated with mitosis. There was no association between p53 expression with mitosis. There was no association between p53 or mitosis with histological subtype of synovial sarcoma, with tumor location, and with gender (Table 3) . Of the seven FISH positive cases, p53 expression was not associated with mitosis (Table 4) .
DISCUSSION
In this study, synovial sarcoma cases occurred in the age ranged from young to old and their average age was adult, while the proportion of cases in both sexes were equal. Characteristics of the subjects were similar to those reported by Oda et al. 8 In this study, the tumor was found at the extremity, head Some cases expressing p53. This result was similar to that reported by Oda et al 8 and Schneider-Stock et al. 11 In synovial sarcoma, p53 should decreases as reported by D'Arcy et al 4 , though the soft tissue tumors may have increased expression of p53 and this is associated with poor prognosis. 12 Several processes can increase p53 expression such as telomere shortening, DNA damage, oxidative stress, oncogenic stress and Ras activation. 13 Therefore in this study possible causes need to be further investigated. Moreover Oda et al 8 and SchneiderStock et al 11 reported in some cases with p53 expression have no p53 mutated.
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Figure 2. p53 expression in synovial sarcoma. (A) p53 positive expression case, several nucleus were brown stained by DAB (arrows), (B) Case with negative p53 expression, (C) positive control (breast tumors), (D) negative control. (Immunohistochemistry staining , 40x objective lens)
Expression of p53 were observed in this study due to the increased expression of mutant p53 can not be ruled out, because the primary antibody that we were used can reacts to both p53 wild-type and mutant. 14 11 reported p53 expression in synovial sarcoma some are mutants. In addition to functioning as a tumor suppressor p53 can serve as an oncoprotein if it is mutated. 15 Although Oda et al 8 also reported no association between p53 expression with p53 mutations, in these study whether p53 mutations were involved in the tumor pathogenesis was not known.
Oda et
In synovial sarcoma high number of mitosis increases histological degree with poor prognosis. Table 4 . p53 expression and mitosis of the cases with SYT gene translocation there was no association between p53 expression with mitosis, this is similar as reported by Oda et al. 8 This may indicated that p53 signaling pathway was not the only major factor affecting tumor mitosis. Haldar et al 3 explain there are other signaling pathways that influence synovial sarcoma growth. SYT-SSX fusion proteins can increase expression of factors that promote cell proliferation, such as cyclin D1, β-catenin, IGF2, IGF-1R, ERK1, ERK2, p-ERK and can decreased expression of factors that suppress cell proliferation, such as EGR1 and COM1. 17 Because this study was conducted in population different from previous studies, there was possibility p53 and HDM2 polymorphism influence tumor mitosis. Although this is not the cause of malignancy, polymorphism may affect both protein activity and may influence tumor pathogenesis as well.
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In this study, tumor diameter was not associated with mitosis. Tumor diameter should relate to the number of mitosis, the higher mitotic number the greater tumor size. Therefore in this study tumor proliferation should be further confirmed by Ki-67 examination.
Almost all synovial sarcoma presents translocation between SYT gene on chromosome 18 with SSX gene on chromosome X. 2 This translocation can be detected by FISH or RT-PCR. 19 FISH method as described in figure 1 has been proved by Amary et al 9 and Motoi et al. 20 Unfortunately, in this study a positive FISH obtained only in 7/19 cases. The FISH results was different from the number of histopathologic diagnosis. Amary et al 9 reported that not all cases showed SYT gene translocation by FISH. This is because the FISH method may occur difficulty if one signal partner disappears or if there are SYT gene amplification, we also experienced the same thing. Amary et al 9 reported in some of FISH negative cases, SYT-SSX fusion transcripts can be detected by PCR or RT-PCR. There was a possibility that the FISH negative cases were not synovial sarcoma as tumor histologically may resemble malignant peripheral nerve sheath tumor. 2 Amary et al 9 reported the cases with negative SYT-SSX fusion gene based on other tests obtained diagnosis other p: Fisher's Exact test two-tail than synovial sarcoma. Therefore, in this study further investigations are needed to confirm the results of negative FISH.
Of seven positive FISH cases showed no association between p53 expression with mitosis. Mitosis can be influenced by SYT-SSX fusion gene subtype. 16 Inagaki et al 16 reported SYT-SSX1 fusion gene associated with high expression of Ki-67 and high mitotis compared with SYT-SSX2 fusion gene. Although there was no association between SYT-SSX fusion gene subtype with p53 expression, 16 in this study to investigate the role of SYT-SSX fusion gene subtype, PCR or qRT-PCR is needed.
SYT-SSX fusion gene subtype associated with synovial sarcoma histological subtype, mitosis and Ki67. 16 In this study showed no correlation between histological type with p53 expression and with mitosis. These results were consistent with reports of Schneider-Stock et al 11 and Oda et al. 8 SYT-SSX1 translocation subtype associated with glandular epithelial differentiation than SYT-SSX2. Expression of E-cadherin reported to be associated with the phenotype of SYT-SSX1 and glandular biphasic morphology. 12 Furthermore Derksen et al 21 reported that the loss of expression of E-cadherin and p53 synergize to form breast tumors that grow faster and invasive in mice. Therefore role of both factors in histological subtypes of synovial sarcoma may be important and need to be further studied.
In this study, there was an association between tumor diameter <5 cm with positive p53 expression. The result was in contrast to reports of Oda et al. 8 This indicated that positive p53 expression suppresses tumor growth and conversely negative p53 expression promotes tumor growth. Wild-type p53 has function as a tumor suppressor, therefore it was possible that p53 expressed in this study were wild-type. This finding should be further clarified by performing p53 mutation examination.
In this study showed no significant difference p53 expression and mitosis between male and female patients. This was similar as reported by Oda et al. 8 This indicated that sex hormones were not involved in tumor patogensis. These finding is supported by reports of Bhargava et al 22 that of the 16 cases were studied revealed no expression of estrogen receptor and progesterone receptor found only in one case.
In conclusion, the positive p53 expression in synovial sarcoma associated with tumor diameter <5 cm, although not related to mitosis. While between biphasic and monophasic subtype of synovial sarcoma there is no difference of p53 expression and mitosis.
